MedTrace Logo

Prophylactic Antibiotics in Groin Hernioplasty

NCT07111702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-13

No results posted yet for this study

Summary

The role of prophylactic antibiotics in preventing surgical site infections (SSI) for clean procedures like groin hernia repair remains controversial. This study aimed to evaluate the association between antibiotic prophylaxis and SSI rates in a real-world clinical setting and to identify independent risk factors for SSI. The study prospectively followed 100 male patients undergoing elective open groin hernioplasty. Patients were categorized based on the surgeon's decision into two groups: those who received a single dose of intravenous cefazolin (Antibiotic Group) and those who did not (No Antibiotic Group). The main outcome was the rate of SSI within 30 days of surgery.

Conditions

  • Surgical Site Infection
  • Groin Hernia
  • Hernioplasty

Interventions

DRUG

Cefazolin

A single 2g intravenous dose administered once before surgery.

Sponsors & Collaborators

  • Al-Gumhori Teaching Hospital

    collaborator UNKNOWN

  • Sana'a University

    lead OTHER

Principal Investigators

  • Waleed Mohammed Gilan, Asssociate Professor · Faculty of Medicine and Health Sciences, Sana'a University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • Yemen

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07111702 on ClinicalTrials.gov